IP Library Granted Patent US 10,030,232
Granted Patent B2
US 10,030,232 · App. 14/898,506 · Granted Jul 24, 2018

Methods for preparing inactivated rotavirus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,030,232
App. No.
14/898,506
Granted
Jul 24, 2018
Kind
B2
Abstract

Disclosed are methods for production of inactivated rotavirus directly from cell culture supernatants containing active or infectious rotavirus (e.g., bovine rotavirus), without prior isolation or purification of the rotavirus from the cell culture supernatants. In some embodiments, inactivated rotavirus (e.g., bovine rotavirus) is produced by heating a volume of culture supernatant to at least a temperature at which the rotavirus is inactivated. In some embodiments, the rotavirus (e.g., bovine rotavirus) is inactivated once the entire volume is heated to at least a temperature at which the rotavirus is inactivated. In some embodiments, the temperature of the cell culture supernatant is maintained for a suitable amount of time, which may be determined using any of the tests described herein. Inactivated rotavirus (e.g., bovine rotavirus) may then be isolated from the culture supernatant.

Claims (24)

1. A method for producing inactivated rotavirus, comprising directly heating a volume of cell culture supernatant containing active unmanipulated rotavirus to a temperature at which the rotavirus is inactivated;

wherein the temperature is about 60-80° C.

2. The method of claim 1 , wherein the cell culture supernatant does not have one or more of:

an osmolality in the range of 200-500 mOsm,

a concentration of a salt of a divalent cation in the range of about 1 mM to 15 mM, and

a sugar and/or sugar alcohol in the range of about 1 to 20% weight/volume.

3. The method of claim 1 , wherein the inactivated rotavirus is immunogenic.

4. The method of claim 3 , wherein the inactivated rotavirus elicits a higher geometric mean titer of virus neutralizing antibodies than a rotavirus inactivated chemically.

5. The method of claim 1 , wherein the rotavirus is a bovine rotavirus.

6. The method of claim 1 , wherein the temperature is about 70° C.

7. The method of claim 1 , wherein the temperature of the culture supernatant is maintained for about 15 minutes to about 240 minutes.

8. The method of claim 1 , wherein the temperature of the culture supernatant is maintained for about 15 minutes to about 60 minutes.

9. The method of claim 1 , wherein the temperature of the culture supernatant is maintained for about 60 minutes.

10. The method of claim 1 , further comprising subsequently heating the cell culture supernatant in at least two separate steps.

11. The method of claim 1 , wherein the pH of the cell culture supernatant is 7.6±0.1.

12. A composition comprising rotavirus inactivated by directly heating a volume of cell culture supernatant containing active unmanipulated rotavirus to a temperature at which the rotavirus is inactivated;

wherein the temperature is about 60-80° C.; and

wherein the temperature is maintained for about 15 to 240 minutes.

13. The composition of claim 12 , further comprising an adjuvant.

14. The composition of claim 12 , further comprising one or more pharmaceutically acceptable carriers.

15. The composition of claim 12 , further comprising at least one antigen from an infectious agent other than rotavirus.

16. A method for stimulating an immune response in a subject, comprising administering to the subject the composition of claim 12 .

17. The method of claim 16 , wherein the subject is a bovine animal.

18. The method of claim 16 , wherein the composition is administered to the subject via a route selected from the group consisting of subcutaneous, intravenous, intramuscular, intradermal, intranodal, intranasal, and oral.

Assignments (4)
CHANGE OF NAME Recorded Aug 23, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 043363/0007 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2015
From: DEKKER, BRENT E.; HERBERT, JOHN M.; REIMNITZ, MICHAEL J.
To: NOVARTIS ANIMAL HEALTH US INC.
Reel/Frame 037325/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2015
From: NOVARTIS ANIMAL HEALTH US INC.
To: NOVARTIS AG
Reel/Frame 037325/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2015
From: NOVARTIS AG
To: NOVARTIS TIERGESUNDHEIT AG
Reel/Frame 037325/0674 →